Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors.
Hematol Oncol
; 28(2): 82-8, 2010 Jun.
Article
in En
| MEDLINE
| ID: mdl-19768693
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Thiazoles
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Fusion Proteins, bcr-abl
/
Point Mutation
/
Drug Resistance, Neoplasm
/
Mutation, Missense
/
Protein Kinase Inhibitors
/
Antineoplastic Agents
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Hematol Oncol
Year:
2010
Document type:
Article